ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

June 16, 2006

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994